scorecard

You Searched For "adar poonawalla" and got 17 results


Sort By:


Business Insider Latest Story Image
2 mins read

Adar Poonawalla gets 50% stake in Karan Johar's Dharma Productions for ₹1,000 crore

Adar Poonawalla’s Serene Productions acquires a 50% stake in Karan Johar’s Dharma Productions and D…

Business Insider Latest Story Image
2 mins read

Govt likely to float global tender for HPV vaccine in April; Merck, Serum Institute may participate

The Health Ministry intends to roll out HPV vaccine against cervical cancer in the national immunis…

PTI   


Business Insider Latest Story Image
1 min read

Covovax vaccine to get approval as a booster in 10-15 days: Adar Poonawalla

Asked about states and districts not getting Covishield vaccine, he said there is ample stock wi…

PTI   


Business Insider Latest Story Image
2 mins read

Global rollout of 12 billion Covid-19 vaccine doses largest-ever, but access is an issue: WHO

Addressing the annual general meeting of the Developing Countries Vaccine Manufacturers Network …

Business Insider Latest Story Image
2 mins read

More than 3.3 million people lost life to COVID-19 in 2021 — more than HIV, malaria and tuberculosis related deaths combined in 2020

The World Health Organisation (WHO), on Tuesday, revealed that more than 3.3 million people lost th…

Business Insider Latest Story Image
1 min read

Serum Institute to roll out COVID-19 vaccine for children in six months, says CEO Adar Poonawalla

"We haven't seen a lot of severe disease in children. Fortunately, the panic is not there fo…

PTI   


Business Insider Latest Story Image
3 mins read

US-based biotechnology company Novavax’s COVID-19 shot is 90% effective

US-based biotechnology company Novavax's protein-based vaccine has shown overall 90 per cent effica…

Business Insider Latest Story Image
1 min read

Adar Poonawalla-backed pharmacy chain Wellness Forever files for IPO

Apart from a fresh issue worth up to ₹400 crore, there will be an Offer for Sale (OFS) wherein…

PTI   


Business Insider Latest Story Image
3 mins read

Adar Poonawalla's Serum cuts Covishield vaccine price for state governments to ₹300 a dose after much backlash

In a tweet, Poonawalla called this cut a "philanthropic gesture" that will save crores of rupees…

Business Insider Latest Story Image
3 mins read

If 2015 was the ‘Year of the API’, why is there a Remdesivir shortage six years later?

Catchphrases don’t cure, actual drugs do. In fact, since 2015, the year when the government…

Business Insider Latest Story Image
1 min read

Serum Institute's second COVID-19 vaccine 'Covavax' likely to be launched in September

Serum Institute of India, the world's biggest Covid-19 vaccine maker, is hopeful to launch Covovax …

Business Insider Latest Story Image
2 mins read

SII CEO believes 'vaccine nationalism' in India and the US could derail efforts to deliver two billion doses to poorer nations

Adar Poonawalla, CEO, Serum Institute of India (SII) has said that vaccine nationalism in countries…

Business Insider Latest Story Image
2 mins read

India’s vaccine king Adar Poonawalla will pay $69,000 a week to live on the same neighbourhood as Winston Churchill once did

Poonawalla, who is an alumnus of the University of Westminster, has often referred to London…

Business Insider Latest Story Image
4 mins read

PTI   


Business Insider Latest Story Image
2 mins read

Here's an indicative timeline for the Oxford vaccine — from phase-3 trials to the final supply in the market

SII, the world’s largest vaccine manufacturer, earlier in April, partnered with the University o…

Business Insider Latest Story Image
2 mins read

Biocon Biologics to offer 15% stake to Serum Institute Life Sciences at valuation of $4.9 billion

In addition to vaccines, the strategic alliance will also develop antibodies targeting seve…

PTI   


Business Insider Latest Story Image
2 mins read

The Oxford COVID-19 vaccine will only cost the Indian government $3 per dose, reveals Adar Poonawalla

The CEO of Serum Institute of India (SII), the company conducting the clinical trials of the vac…